Journal of Clinical Pharmacy and Therapeutics

Papers
(The H4-Index of Journal of Clinical Pharmacy and Therapeutics is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in CO62
A review of GLP‐1 receptor agonists in type 2 diabetes: A focus on the mechanism of action of once‐weekly agents49
Safety and tolerability of once‐weekly GLP‐1 receptor agonists in type 2 diabetes47
Analysis of the clinical characteristics, drug treatments and prognoses of 136 patients with coronavirus disease 201940
Long‐term efficacy and safety of hypoxia‐inducible factor prolyl hydroxylase inhibitors in anaemia of chronic kidney disease: A meta‐analysis including 13,146 patients40
Comparative efficacy and safety of tofacitinib, baricitinib, upadacitinib, filgotinib and peficitinib as monotherapy for active rheumatoid arthritis39
Use of inhibitors of the renin‐angiotensin system in hypertensive patients and COVID‐19 severity: A systematic review and meta‐analysis38
Efficacy and safety of remimazolam tosylate in hysteroscopy: A randomized, single‐blind, parallel controlled trial36
Meropenem use and therapeutic drug monitoring in clinical practice: a literature review34
The effect of metformin on lung cancer risk and survival in patients with type 2 diabetes mellitus: A meta‐analysis29
Clinical effects of low‐dose esketamine for anaesthesia induction in the elderly: A randomized controlled trial27
Neurotoxicity associated with acyclovir and valacyclovir: A systematic review of cases24
Haematologic toxicities with PARP inhibitors in cancer patients: an up‑to‑date meta‑analysis of 29 randomized controlled trials24
Clinical effects and safety of edaravone in treatment of acute ischaemic stroke: A meta‐analysis of randomized controlled trials23
Safety of tocilizumab in COVID‐19 pregnant women and their newborn: A retrospective study22
The effect of anti‐Xa monitoring on the safety and efficacy of low‐molecular‐weight heparin anticoagulation therapy: A systematic review and meta‐analysis21
Observational study of the effects of Favipiravir vs Lopinavir/Ritonavir on clinical outcomes in critically Ill patients with COVID‐1920
Risk factors for tigecycline‐induced hypofibrinogenaemia20
ED 50 and ED 95 of propofol combined with different doses of esketamine for children undergoing upper gastrointestinal endoscopy: 20
A current review of the safety of cystic fibrosis transmembrane conductance regulator modulators20
0.036941051483154